Immunoglobulin G anticardiolipin antibodies and progression to Q fever endocarditis

Clinical Infectious Diseases

Volumn 57, Issue 1, 2013, Pages 57-64

  Million, Matthieu ^a   Walter, Gaëlle ^a   Bardin, Nathalie ^b   Camoin, Laurence ^a,c   Giorgi, Roch ^b,c   Bongrand, Pierre ^b   Gouriet, Frédérique ^a   Casalta, Jean Paul ^a   Thuny, Franck ^c   Habib, Gilbert ^c   Raoult, Didier ^a  

^a CNRS   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

anticardiolipin; antiphospholipid; Coxiella burnetii; endocarditis; Q fever

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; DISEASE COURSE; ENDOCARDITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; Q FEVER; VALVULAR HEART DISEASE;

ANTICARDIOLIPIN; ANTIPHOSPHOLIPID; COXIELLA BURNETII; ENDOCARDITIS; Q FEVER;

ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ENDOCARDITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PROGNOSIS; Q FEVER;

EID: 84878825013     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit191     Document Type: Article

References (27)

1. Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999; 12:518-53. (Pubitemid 29484745)
2. van der HoekW, Versteeg B, Meekelenkamp JC, et al. Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis 2011; 52:1431-6.
3. Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 2001; 33:312-6. (Pubitemid 32664833)
4. Raoult D, Etienne J, Massip P, et al. Q fever endocarditis in the south of France. J Infect Dis 1987; 155:570-3. (Pubitemid 17032819)
5. Mogollon MV, Anguita MP, Aguado JM, et al. Q fever endocarditis in Spain. Clinical characteristics and outcome. Enferm Infecc Microbiol Clin 2011; 29:109-16.
6. Siegman-Igra Y, Kaufman O, Keysary A, Rzotkiewicz S, Shalit I. Q fever endocarditis in Israel and a worldwide review. Scand J Infect Dis 1997; 29:41-9.
7. Million M, Thuny F, Richet H, Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis 2010; 10: 527-35.
8. Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 2000; 79:109-23. (Pubitemid 30205512)
9. Lefebvre M, Grossi O, Agard C, et al. Systemic immune presentations of Coxiella burnetii infection (Q fever). Semin Arthritis Rheum 2010; 39:405-9.
10. Levy P, Raoult D, Razongles JJ. Q-fever and autoimmunity. Eur J Epidemiol 1989; 5:447-53. (Pubitemid 20063622)
11. Ordi-Ros J, Selva-O'Callaghan A, Monegal-Ferran F, Monasterio-Aspiri Y, Juste-Sanchez C, Vilardell-Tarres M. Prevalence, significance, and specificity of antibodies to phospholipids in Q fever. Clin Infect Dis 1994; 18:213-8. (Pubitemid 24055261)
12. D'Alton JG, Preston DN, Bormanis J, Green MS, Kraag GR. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 1985; 16:512-4. (Pubitemid 15034438)
13. Zuily S, Regnault V, Selton-Suty C, et al. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation 2011; 124:215-24.
14. Sergakova LM, Fomicheva OA, Vil'chinskaia MI, et al. Involvement of cardiac valves in antiphospholipid syndrome. Klin Med (Mosk) 1996; 74:39-42.
15. Bouillanne O, Millaire A, De GP, et al. Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: a casecontrol study. Am Heart J 1996; 132:790-5. (Pubitemid 26366978)
16. Million M, Lepidi H, Raoult D. Q fever: current diagnosis and treatment options. Med Mal Infect 2009; 39:82-94.
17. Raoult D. Chronic Q fever: expert opinion versus literature analysis and consensus. J Infect 2012; 65:102-8.
18. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-8.
19. Tissot-Dupont H, Thirion X, Raoult D. Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol 1994; 1:189-96. (Pubitemid 2057614)
20. Stein A, Raoult D. Detection of Coxiella burnetti by DNA amplification using polymerase chain reaction. J Clin Microbiol 1992; 30: 2462-6.
21. Lancellotti P, Tribouilloy C, Hagendorff A, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr 2010; 11:223-44.
22. Raoult D, Million M, Thuny F, Carrieri P. Chronic Q Fever detection in the Netherlands. Clin Infect Dis 2011; 53:1170-1.
23. Verrot D, San-Marco M, Dravet C, et al. Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am J Med 1997; 103:33-7. (Pubitemid 27314185)
24. Marrie TJ, Cunning J, Durnford P. Reactivation of Q fever following cardiac surgery. Eur J Clin Microbiol Infect Dis 1992; 11:833-6.
25. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007; 335:806-8. (Pubitemid 350057266)
26. Frankel D, Richet H, Renvoise A, Raoult D. Q fever in France, 1985-2009. Emerg Infect Dis 2011; 17:350-6.
27. Hartzell JD, Gleeson T, Scoville S, Massung RF, Wortmann G, Martin GJ. Practice guidelines for the diagnosis and management of patients with Q fever by the Armed Forces Infectious Diseases Society. Mil Med 2012; 177:484-94.